Compare ARTL & NCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARTL | NCL |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 3.7M |
| IPO Year | N/A | 2023 |
| Metric | ARTL | NCL |
|---|---|---|
| Price | $5.86 | $0.16 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 327.8K |
| Earning Date | 05-12-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,349,854.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.86 |
| 52 Week Low | $0.85 | $0.10 |
| 52 Week High | $28.60 | $1.47 |
| Indicator | ARTL | NCL |
|---|---|---|
| Relative Strength Index (RSI) | 50.95 | 50.87 |
| Support Level | $2.24 | $0.14 |
| Resistance Level | $6.16 | $0.17 |
| Average True Range (ATR) | 2.41 | 0.02 |
| MACD | -0.28 | 0.00 |
| Stochastic Oscillator | 17.37 | 78.99 |
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. It offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, mainly through its sales network in North America and Europe.